Geneos Wealth Management’s Confluent CFLT Stock Holding History

Geneos Wealth Management’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-60	Closed	-$1.5K	–	2609
2025 Q2	$1.5K	Sell	60 -384	-86%	-$8.65K	﹤0.01%	2884
2025 Q1	$10.4K	Buy	444 +368	+484%	+$10.7K	﹤0.01%	2555
2024 Q4	$2.13K	Buy	+76	New	+$2.04K	﹤0.01%	2581
2024 Q1	–	Sell	-103	Closed	-$2.41K	–	2143
2023 Q4	$2.41K	Sell	103 -500	-83%	-$12.1K	﹤0.01%	1882
2023 Q3	$17.9K	Hold	603	–	–	﹤0.01%	1414
2023 Q2	$21.3K	Buy	603 +530	+726%	+$14.8K	﹤0.01%	1356
2023 Q1	$1.76K	Sell	73 -600	-89%	-$13.9K	﹤0.01%	1927
2022 Q4	$15K	Hold	673	–	–	﹤0.01%	1418
2022 Q3	$15K	Sell	673 -800	-54%	-$21.6K	﹤0.01%	1407
2022 Q2	$36K	Buy	1,473 +403	+38%	+$10.8K	﹤0.01%	1415
2022 Q1	$43K	Buy	+1,070	New	+$55.8K	﹤0.01%	1446

Other funds holding CFLT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

OPFM

Optimus Prime Fund Management Grand Cayman, Cayman Islands $1.04B AUM 9.64% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's CFLT Position: Q3 2025 in Review

Geneos Wealth Management sold out of Confluent (CFLT) in Q3 2025, closing a stake of 60 shares — an estimated $1.5K sold.

Geneos Wealth Management first reported a position in CFLT in Q1 2022 and held it in 11 quarters. The position peaked at $43K in Q1 2022. 385 funds tracked by Wall St. Rank hold CFLT as of Q3 2025.

Geneos Wealth Management reported no remaining Confluent position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 60 Confluent shares in Q3 2025, an estimated $1.5K.
Geneos Wealth Management first reported a position in Confluent in Q1 2022 and held it in 11 quarters.
Geneos Wealth Management's Confluent position peaked at $43K in Q1 2022.
385 funds tracked by Wall St. Rank held Confluent as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.